United States — Food and Drug Administration & Cleveland Clinic
7 shared events · Importance 3 · Last updated Sep 08, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
United States — Food and Drug Administration: The FDA has previously warned about xylitol's danger to dogs, and this study may prompt the agency to review the sweetener's cardiovascular safety in humans.
Cleveland Clinic: Cleveland Clinic conducted earlier research on xylitol and cardiovascular risk, providing foundational evidence that this study builds upon.
Aug 26, 2026 · 50 articles
Tech
United States — Food and Drug Administration: Regulatory body; approval decisions will determine U.S. market access.
Cleveland Clinic: Hospital where Dr. Billow practices; provides clinical perspective.
Sep 05, 2026 · 6 articles
Regulatory
United States — Food and Drug Administration: US regulator that has not added a NAION warning to GLP-1 labels but is conducting an ongoing review through its Sentinel Initiative. Its eventual decision could reshape labeling and prescribing for the entire drug class.
Cleveland Clinic: Medical institution cited for describing NAION, sometimes called Ozempic blindness, as rare but potentially devastating with no established treatment to reverse the damage.
Sep 21, 2026 · 20 articles
Regulatory
United States — Food and Drug Administration: Regulatory body that approved Lipfendra, enabling market entry.
Cleveland Clinic: Affiliation of cardiologist Dr. Steve Nissen, who commented on LDL targets.
Jul 16, 2026 · 93 articles
Accidents
United States — Food and Drug Administration: The FDA is assisting in the outbreak investigation, focusing on food safety and potential contamination sources.
Cleveland Clinic: Medical institution providing symptom information.
Jun 30, 2026 · 348 articles
Accidents
United States — Food and Drug Administration: The FDA led the investigation, identified the source, and oversaw the recall. Its handling of the outbreak may affect its regulatory reputation.
Cleveland Clinic: Provided treatment information for cyclosporiasis.
Jul 10, 2026 · 268 articles
Regulatory
United States — Food and Drug Administration: The FDA planned a meeting of experts to discuss medical use of testosterone in mid-September, reflecting regulatory interest in the hormone's broader use.
Cleveland Clinic: The Cleveland Clinic was cited for data showing testosterone levels in men decline by about 1% to 2% annually after age 30.
Sep 02, 2026 · 84 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Cleveland Clinic interact across events, view sentiment trends, and discover connected entities.
Open Dashboard